Medacta Group SA, CH0468525222

Medacta Group SA, CH0468525222

22.04.2022 - 07:03:39

Medacta Group SA publishes 2022 Annual General Meeting invitation

by May 13, 2022.

The Board of Directors is proposing to the AGM the distribution of CHF 10.7 million or CHF 0.535 per share, half of it to be distributed as dividend out of available earnings and half of it to be distributed out of accumulated reserves from capital contribution.

The Board is proposing the re-election of Dr. Alberto Siccardi as Chairman of the Board of Directors. All current board members stand for re-election.

The Board is also proposing the re-election of the members of the Remuneration Committee and the approval of the maximum amount of compensations for the members of the Board of Directors and the Group Executive Management. Further motions include the re-election of the Independent Proxy Holder and Auditors for the financial year 2022.

All details on the motions can be found in the invitation to the 2022 AGM at Medacta International SA Gianna La Rana, Head of Investor Relations Phone: +41 91 696 14 95 investor.relations@medacta.chAbout MedactaMedacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.

End of Media Release

Language: English Company: Medacta Group SA Strada Regina 6874 Castel San Pietro

Switzerland Phone: +41 91 696 6060 E-mail: Internet: ISIN: CH0468525222 Listed: SIX Swiss Exchange EQS News ID: 1332281 ? End of News EQS News Service